Hi, what are you looking for?
Jewish Business News
Search results for "nyse"
Financial Research
Vehicle collision prevention developer Mobileye (NYSE: MBLY) saw its share price soar to new heights yesterday on Wall Street after nine underwriters initiated coverage...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) Israel-based generic drug maker has entered into an agreement with Venus Remedies to sell anti- cancer drug...
Business
– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. – Changes in the multiple sclerosis treatment market, in which...
Business
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
Business
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
Business
– The generic drug company’s fourth quarter results beat analysts’ estimates. Perrigo Company (NYSE:PRGO; TASE:PRGO) released its fourth quarter and full year results today....
Business
– The declaration will let Delek and Noble sell the fields to avoid being labelled a cartel. – – Delek Group Ltd. (TASE: DLEKG)...
Money
– Salesforce.com, Inc. (NYSE:CRM) CEO Marc Benioff unloaded 20, 000 shares of his stock on the open market last Thursday, August 7, watchlistnews.com...
Court
– Teva confirmed that it will continue to vigorously defend its Copaxone intellectual property rights. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
StartUps
– The Wall Street offering of road accident avoidance technology developer Mobileye(NYSE: MBLY), which raised $1.023 billion a record IPO for an Israeli...